Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 3

Sponsor Class

NIH 36OTHER 33INDUSTRY 21NETWORK 3OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 3Sarcoma 2Other hematologic neoplasm 2CNS 2Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 15Carcinoma, Non-Small-Cell Lung 9Prostatic Neoplasms 8Colorectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Melanoma 7Burkitt Lymphoma 6Pancreatic Neoplasms 5Lung Neoplasms 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Multiple Myeloma 4Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Acute 4Leukemia, Biphenotypic, Acute 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Wilms Tumor 3Osteosarcoma 3Malignant Solid Neoplasm 3Lymphoma, Non-Hodgkin 3Lymphoma 3Hematologic Neoplasms 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Teratoma 2Squamous Cell Carcinoma of Head and Neck 2Rhabdomyosarcoma, Embryonal 2Recurrence 2

Interventions

Surveys and Questionnaires 1Specimen Handling 1Fluid Therapy 1CBLC137 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Lymphoma × 30 days × Clear all
NCT01790152 2026-05-18

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Children's Oncology Group

Recruiting
420 enrolled
LymphoidOther hematologic neoplasmSarcoma

Leukemia, Lymphoma, Recurrence, Osteosarcoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05108298 2026-05-07

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Eastern Cooperative Oncology Group

Phase NA Recruiting
400 enrolled
BreastCNSDermatologicGastrointestinalGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcoma

Bone Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Leukemia, Lymphoma, Melanoma, Sarcoma, Thyroid Neoplasms, Central Nervous System Neoplasms, Pyloric Stenosis, Hypertrophic

NCT04870944 2026-05-05

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Children's Oncology Group

Phase 1/2 Recruiting
63 enrolled
CNSLymphoid

Diffuse Intrinsic Pontine Glioma, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡